3 completed, 3 recruiting. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Recruiting 3 |
| Phase 2 | 1 | Recruiting 1 |
Follow EC5026: new trials by email Literature Review of EC5026 trials Research Report on EC5026
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Renal Impairment Study for Oral EC5026 EC5026 oral tablet - Chronic Kidney Disease | Phase 1 | Recruiting | EicOsis Human Health Inc. | 18 | 2026-07-01 | 2026-07-10 |
| Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury EC5026 oral tablet, Placebo oral tablet - Spinal Cord Injuries, Neuropathic Pain | Phase 1 | Recruiting | EicOsis Human Health Inc. | 36 | 2026-05-01 | 2026-07-10 |
| Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study) EC5026 oral tablet, Placebo - Parkinson's Disease (PD) | Phase 1 / Phase 2 | Recruiting | EicOsis Human Health Inc. | 18 | 2025-11-01 | 2026-07-10 |
| Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Oral EC5026 in Healthy Subjects EC5026 oral tablet, Placebo oral tablet - Healthy Subjects | Phase 1 | Completed | EicOsis Human Health Inc. | 16 | 2023-11-28 | 2025-01-08 |
| Safety, Tolerability, Pharmacokinetics and Food Effects of Oral EC5026 in Healthy Subjects EC5026 oral tablet, Placebo oral tablet - Healthy Adults | Phase 1 | Completed | EicOsis Human Health Inc. | 18 | 2021-04-30 | 2024-02-20 |
| Safety, Tolerability, and Pharmacokinetics of Oral EC5026 in Healthy Subjects EC5026 oral capsule, Placebo oral capsule - Healthy Adults | Phase 1 | Completed | EicOsis Human Health Inc. | 40 | 2019-12-09 | 2021-07-01 |
Intervertebral Disc Degeneration (1) · Neuralgia (1) · Renal Insufficiency, Chronic (1) · Spinal Cord Injuries (1) · Spinal Stenosis (1) · Spondylosis (1)
United States (5) · New Zealand (1)
William K Schmidt, PhD (3) · Cory D Sellwood, MBChB (1) · Lin Zhang, MD, PhD (1)
1UH2NS094258-01 (1)